Centre Marie Curie
- Address
- 159 boulevard du Maréchal Juin, 26000 Valence, France
Centre Marie Curie - Head and Neck Cancer Research
Centre Marie Curie specializes in advanced oncology research with a particular focus on head and neck malignancies. The center conducts cutting-edge clinical trials investigating optimal treatment strategies for complex tumors affecting the sinuses and salivary glands, contributing to the development of evidence-based therapeutic protocols for these challenging cancers.
- Comparative studies of radiotherapy versus chemoradiotherapy in adjuvant settings
- Treatment protocols for resected and non-operable tumors of sinuses and major salivary glands
- Progression-free survival outcomes in head and neck carcinomas
The research center's clinical trial portfolio emphasizes multidisciplinary approaches to treating both resectable and non-operable malignancies of the sinuses and salivary glands. Their investigations into adjuvant therapy optimization aim to establish superior treatment regimens that balance efficacy with patient quality of life, particularly focusing on carcinomas of major salivary glands and malignant tumors of the sinuses.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Unicancer1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Marie Curie
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Pembrolizumab, Chemotherapy, and Radiotherapy in Advanced Non-Small Cell Lung Cancer: A Randomized Controlled Trial | Unicancer | Phase III | Recruiting | Mar 2019 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cisplatin | 3 | Unknown | 2017-01-30 | 2019-03-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.